Business Context and Reporting Period
Company: Universal Health Services, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 1994
Business Overview: The Company operates acute care hospitals, psychiatric hospitals, and ambulatory treatment centers. Operations are influenced by shifts toward outpatient care, managed care growth, and government reimbursement programs.
Key Financial Metrics
| Metric (in thousands) | Q1 1994 | Q1 1993 |
|---|---|---|
| Net Revenues | $194,432 | $195,305 |
| Net Income | $10,287 | $8,611 |
| Earnings Per Share | $0.72 | $0.60 |
| Operating Cash Flow | $11,289 | $13,708 |
| Free Cash Flow (Approx.) | ($332) | ($1,552) |
| Total Debt (Current + Long-term) | $83,664 | N/A |
| Cash and Equivalents | $2,799 | N/A |
Note: Free Cash Flow calculated as Operating Cash Flow less Property and Equipment additions ($11,871).
Material Changes vs. Prior Period
- Revenue: Total net revenues decreased slightly by 0.4% year-over-year. However, excluding special Medicaid programs, revenues from hospitals owned in both periods increased 7%.
- Profitability: Net income increased 19.5% to $10.3 million, driven by a 27.9% increase in income before taxes.
- Operating Expenses: Excluding special Medicaid revenues, operating expenses as a percentage of net revenue decreased from 85% in Q1 1993 to 82% in Q1 1994.
- Interest Expense: Decreased 31% to $1.8 million due to lower average outstanding borrowings.
- Segment Performance:
- Acute Care: Revenues increased 9% due to a 10% rise in admissions and 9% rise in patient days.
- Psychiatric: Revenues decreased 9% due to an 8% decline in patient days, despite a 7% increase in admissions, as average length of stay dropped 14%.
Guidance, Outlook, and Risks
- Outlook: Management expects growth in outpatient services to continue, though the rate may moderate. Revenues from Medicare and Medicaid are expected to increase due to population aging and program expansion.
- Unusual Items:
- 1994: Includes $3.0 million in special Medicaid revenues and $2.5 million in expenses related to business dispositions.
- 1993: Included $4.6 million in special Medicaid revenues and $4.1 million in disposition expenses.
- Risks and Contingencies:
- Medicaid Programs: Special reimbursement programs contributing to revenue are scheduled to terminate in August 1994; continuation is uncertain.
- Healthcare Reform: Uncertainty regarding national and state efforts to contain costs and reform healthcare payments.
- Inflation: Operating margins face pressure as Medicare fixed payment rate increases historically lag behind actual inflation.
- Subsequent Events: Post-period, the Company acquired four radiation therapy centers for $5.9 million in cash.
Investor Verification Checklist
- Verify the sustainability of revenue growth once the special Medicaid reimbursement programs terminate in August 1994.
- Confirm the impact of the 14% decrease in psychiatric patient length of stay on future profitability.
- Review the details of the $24 million in commitments and guarantees related to self-insurance and debt support.
- Assess the integration and performance of the four newly acquired radiation therapy centers.
- Monitor the effective tax rate, which rose to 38.7% in Q1 1994 compared to 34.4% in the prior year.